Infectious disease companies develop technologies, diagnostics and therapeutics that prevent, detect and treat bacterial, viral, fungal and parasitic infections. Their work supports global health, outbreak response and disease surveillance.
This category includes companies working on:
Browse 99 UK infectious disease companies below.
Drug-free nasal barrier spray blocking airborne viruses and allergens
Birmingham Biotech is a University of Birmingham spin-out selling NoriZite, a drug-free nasal spray that creates a structured fluid-gel barrier in the nasal cavity for up to six…
Global commercialisation of specialty, hospital and rare disease medicines
ADVANZ PHARMA is a global pharmaceutical company focused on the commercialisation of specialty, hospital and rare disease medicines, partnering with biopharma and pharmaceutical…
Bacillus spore-based vaccines, drug delivery and probiotic therapeutics developer
SporeGen is a biotechnology company working exclusively on spore-forming Bacillus bacteria to develop vaccines, drug delivery platforms and probiotic therapeutics. The company's…
Molecular serotyping microarrays and surveillance services for vaccine pathogens
BUGS Bioscience is a not-for-profit biotechnology spin-out of the Bacterial Microarray Group at St George's, University of London. The company develops and provides molecular…
Broad-spectrum intranasal antivirals targeting respiratory viral infections
Pneumagen is a Scottish clinical-stage biotechnology company developing broad-spectrum intranasal antiviral therapies. Pneumagen’s platform generates multivalent carbohydrate…
Novel mRNA technology platform for safer, faster vaccines
CamMed Therapeutics (Cambridge Medixine Ltd) is a preclinical biotechnology company developing a novel mRNA technology platform for vaccines and therapeutics. Inspired by natural…
CRO specialising in human challenge trials
hVIVO is a specialist contract research organisation providing human challenge trial services for infectious and respiratory disease. The company conducts controlled human…
Portable PCR platform for decentralised genetic testing anywhere
Hyris is a biotechnology company developing a portable, IoT-integrated PCR platform for decentralised nucleic acid testing outside traditional laboratory settings. Its instrument…
Ultra-fast PCR point-of-care diagnostics from swab to result
LEX Diagnostics is a molecular diagnostics company developing rapid point-of-care PCR testing through its proprietary thermal cycling platform. Its system delivers quantitative…
Synthetic mycolic acid antigens and point-of-care TB diagnostics
Diagnostig is a Welsh diagnostics and chemical synthesis company developing point-of-care immunoassay devices for the diagnosis of mycobacterial infections, including human and…
Rapid point-of-care antibiotic susceptibility testing for antimicrobial resistance
Microplate Dx is a diagnostics biotechnology company developing a rapid antibiotic susceptibility testing platform for use at the point of care. Its biosensor technology uses…
Natural antimicrobial solutions to reduce livestock antibiotic use
Feed, Food & Future is a life sciences company developing and testing natural antibacterial and antiviral ingredients for the animal feed and livestock industries. Operating from…